Navigation Links
Accuray to Report Financial Results for Fourth Quarter and Year End Fiscal 2013

SUNNYVALE, Calif., Aug. 7, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) today announced that it will report results for its fourth quarter and fiscal year ended June 30, 2013 on Tuesday, August 27, 2013 after the market closes.

A conference call to review the results will begin at 2:00 p.m. PDT/5:00 p.m. EDT and will be hosted by Joshua H. Levine, president and chief executive officer and Derek Bertocci, senior vice president and chief financial officer.

The conference call dial-in numbers are 1-877-415-3183 (USA) or 1-857-244-7326 (International), Conference ID: 43627074. In addition, a dial-up replay of the conference call will be available beginning August 27, 2013 at 4:00 p.m. PDT/7:00 p.m. EDT and ending on September 3, 2013. The replay telephone number is 1-888-286-8010 (USA) or 1-617-801-6888 (International), Conference ID:  14266989.

A live webcast of the call will also be available from the Investor Relations section of the corporate website at A webcast replay can be accessed on the corporate website beginning Tuesday, August 27, 2013 at approximately 5:00 p.m. PDT/8:00 p.m. EDT.  The replay will remain available until Accuray announces its results for the first quarter of fiscal 2014, ending September 30, 2013.

About Accuray
Accuray Incorporated (Nasdaq: ARAY), is a radiation oncology company that develops, manufactures and sells personalized, innovative treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. The Company's leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments. For more information, please visit



SOURCE Accuray Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
2. Accuray Announces Results for Third Quarter Fiscal 2012
3. Accuray Appoints Richard Pettingill, LFACHE to Board of Directors
4. Accuray and the German Cancer Research Center Sign Master Research and Collaboration Agreement
5. Accuray Incorporated to Speak at Jefferies Global Healthcare Conference
6. Accuray Incorporated to Speak at Wells Fargo Healthcare Conference
7. Accuray Rolls Out Comprehensive Customer Service Program in Japan
8. One Year After TomoTherapy Acquisition, Accuray on Track to Meet or Exceed Integration Success Metrics And Expecting Near-term Return to Profitability
9. Accuray and Erasmus Medical Center Sign Master Research and Collaboration Agreement
10. Accuray to Acquire Morphormics, Inc.
11. Accuray Incorporateds CEO to Speak at Morgan Stanley Global Healthcare Conference
Post Your Comments:
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
(Date:9/19/2017)... a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses pulsed ...   ... Jim Bertolina, ... Tom Tefft ... medical device executive Josh Stopek , PhD, who has led R&D and business development ...
(Date:9/18/2017)... Sept. 18, 2017 EpiVax, Inc. ... bioinformatics and immune engineering, today announced a ... A (H7N9) vaccine. ... seasonal influenza and presents a challenge for ... exposure to be effective. Using state-of-the-art bioinformatics and ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: ... “America On The Brink” is the creation of published author, William Nowers. ... As a WWII veteran, he spent thirty years in the Navy. Following ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... to meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s ... experts and tested to meet the highest standard. , These products are ...
(Date:10/12/2017)... ... ... The American College of Medical Informatics (ACMI) will present the 2017 Morris ... of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is taking ... in the field of medical informatics, this prestigious award is presented to an individual ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
Breaking Medicine News(10 mins):